Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Morgenstern

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Molecular Pharmaceutics|July 18, 2022
Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter <sup>213</sup>BiAdrianna Cytryniak, Kinga Żelechowska-Matysiak, Ewa Nazaruk, et al.
International Journal of Molecular Sciences|December 9, 2023
Comparative Analysis of Morphological and Functional Effects of <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA Radioligand Therapies (RLTs) on Salivary GlandsBenedikt Feuerecker, Andrei Gafita, Thomas Langbein, et al.
Neoplasia (New York, N.Y.)|May 28, 2014
Antitumor immunity induced after α irradiationJean-Baptiste Gorin, Jérémie Ménager, Sébastien Gouard, et al.
Theranostics|January 3, 2017
Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging AgentsReinier Hernandez, Sandra Heskamp, Mark Rijpkema, et al.
Biochimica Et Biophysica Acta|February 26, 2014
Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutesPinakin Sukthankar, L Adriana Avila, Susan K Whitaker, et al.
Plos Medicine|November 9, 2006
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteinsEkaterina Dadachova, Mahesh C Patel, Sima Toussi, et al.
Cancer Biology & Therapy|August 6, 2005
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595Chang F Qu, Yan J Songl, Syed M A Rizvi, et al.
BMC Cancer|January 29, 2024
Evaluation of the tolerability and safety of [<sup>225</sup>Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation studySui Wai Ling, Astrid A M van der Veldt, Mark Konijnenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2018
Safety and efficacy of targeted alpha therapy with <sup>213</sup>Bi-DOTA-substance P in recurrent glioblastomaLeszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
Medecine Sciences : M/S|May 4, 2016
[Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity]Jérémie Ménager, Jean-Baptiste Gorin, Nolwenn Fichou, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Molecular Pharmaceutics|July 18, 2022
Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter <sup>213</sup>BiAdrianna Cytryniak, Kinga Żelechowska-Matysiak, Ewa Nazaruk, et al.
International Journal of Molecular Sciences|December 9, 2023
Comparative Analysis of Morphological and Functional Effects of <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA Radioligand Therapies (RLTs) on Salivary GlandsBenedikt Feuerecker, Andrei Gafita, Thomas Langbein, et al.
Neoplasia (New York, N.Y.)|May 28, 2014
Antitumor immunity induced after α irradiationJean-Baptiste Gorin, Jérémie Ménager, Sébastien Gouard, et al.
Theranostics|January 3, 2017
Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging AgentsReinier Hernandez, Sandra Heskamp, Mark Rijpkema, et al.
Biochimica Et Biophysica Acta|February 26, 2014
Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutesPinakin Sukthankar, L Adriana Avila, Susan K Whitaker, et al.
Plos Medicine|November 9, 2006
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteinsEkaterina Dadachova, Mahesh C Patel, Sima Toussi, et al.
Cancer Biology & Therapy|August 6, 2005
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595Chang F Qu, Yan J Songl, Syed M A Rizvi, et al.
BMC Cancer|January 29, 2024
Evaluation of the tolerability and safety of [<sup>225</sup>Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation studySui Wai Ling, Astrid A M van der Veldt, Mark Konijnenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2018
Safety and efficacy of targeted alpha therapy with <sup>213</sup>Bi-DOTA-substance P in recurrent glioblastomaLeszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
Medecine Sciences : M/S|May 4, 2016
[Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity]Jérémie Ménager, Jean-Baptiste Gorin, Nolwenn Fichou, et al.
Pageof 18